Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Innospec (IOSP) over the last 17 years, with Q3 2025 value amounting to $270.8 million.

  • Innospec's Cash & Equivalents fell 1086.24% to $270.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.8 million, marking a year-over-year decrease of 1086.24%. This contributed to the annual value of $289.2 million for FY2024, which is 4197.35% up from last year.
  • Innospec's Cash & Equivalents amounted to $270.8 million in Q3 2025, which was down 1086.24% from $266.6 million recorded in Q2 2025.
  • Over the past 5 years, Innospec's Cash & Equivalents peaked at $303.8 million during Q3 2024, and registered a low of $71.4 million during Q2 2022.
  • In the last 5 years, Innospec's Cash & Equivalents had a median value of $165.9 million in 2023 and averaged $185.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 2436.44% in 2022, then skyrocketed by 13235.29% in 2023.
  • Innospec's Cash & Equivalents (Quarter) stood at $141.8 million in 2021, then grew by 3.74% to $147.1 million in 2022, then skyrocketed by 38.48% to $203.7 million in 2023, then soared by 41.97% to $289.2 million in 2024, then fell by 6.36% to $270.8 million in 2025.
  • Its Cash & Equivalents stands at $270.8 million for Q3 2025, versus $266.6 million for Q2 2025 and $299.8 million for Q1 2025.